The healthcare community is excited by retatrutide, a innovative dual GIP and GLP-1 agonist that’s showing remarkable results in early research. This medication works by mimicking natural hormones to regulate appetite and boost feelings of satisfaction , ultimately resulting in considerable weight decrease. While currently under evaluation and no